Novo Nordisk LinkedIn - Search News

News

Novo Nordisk, Concern

The Wall Street Journal on MSN · 2d

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

In April, Danish drugmaker Novo Nordisk formed what was supposed to be a long-term collaboration to promote its weight-loss drug Wegovy on the popular telehealth service Hims & Hers.The deal was Novo Nordisk’s bid to grab back market share from the cheaper,

Reuters on MSN · 2d

Novo Nordisk slides further on US competition, new CEO concerns

Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts warned of persistent competition from copycat drugs in the United States, a day after a profit warning and the naming of a new CEO prompted investors to wipe $70 billion off the drugmaker's value.

Benzinga on MSN · 2d

Novo Nordisk Cuts 2025 Forecasts Again, Shares Drop 17% Amid Wegovy Concerns

Novo Nordisk shares dropped as much as 17% Tuesday after the obesity drugmaker cut its full-year sales and profit outlook for the second time in 2025, according to Reuters. The company cited slowing demand for Wegovy and Ozempic in the U.

10hon MSN

Novo Nordisk shares dip further as Wegovy gains nearly erased

Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent ...

2don MSN

Novo CEO’s First Test Is Winning Back the US Weight-Loss Market

Novo Nordisk A/S’s best-sellers Ozempic and Wegovy transformed the firm into a global pharmaceutical giant. But four years ...

Novo Nordisk Names New Leader, Cuts 2025 Sales Guidance By 5%

In a surprise double announcement Tuesday, Novo reduced sales guidance by 5%—attributing the change to slowed growth of its ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results